licensing agreement

HCW Biologics (HCWB) reported mixed Q2 2025 results. A $5M equity raise helped shore up finances and debt was extinguished. However, revenue plummeted to $6,550, and the Wugen License Agreement was suspended. R&D spending decreased while G&A expenses increased. Despite reducing its net loss, the company expresses doubt about its ability to continue without additional funding. They are seeking new licensing deals and clinical trials are planned. HCWB regained Nasdaq compliance but remains under Panel Monitor.

Guess?, Inc., WHP Global, and Marcolin announced a four-year eyewear licensing deal for their jointly owned rag & bone label, targeting the $114B global market. Launching Q1 2026, the collection blends urban aesthetics with artisanal craftsmanship, reflecting rag & bone’s ethos of merging heritage tailoring with modern utility. Marcolin, leveraging 30+ years in luxury eyewear, will produce angular, versatile designs aligned with Gen Z’s “quiet luxury” trends. The partnership extends rag & bone’s lifestyle offerings post-2024 acquisition, while Marcolin strengthens its premium portfolio after €545.8M revenue in 2023. Distribution spans 48 boutiques, e-commerce, and select retailers, supported by Marcolin’s AI customization tech.